220 related articles for article (PubMed ID: 14978770)
1. Non-physiological overexpression of the low density lipoprotein receptor (LDLr) gene in the liver induces pathological intracellular lipid and cholesterol storage.
Cichon G; Willnow T; Herwig S; Uckert W; Löser P; Schmidt HH; Benhidjeb T; Schlag PM; Schnieders F; Niedzielska D; Heeren J
J Gene Med; 2004 Feb; 6(2):166-75. PubMed ID: 14978770
[TBL] [Abstract][Full Text] [Related]
2. Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade.
Stein CS; Martins I; Davidson BL
J Gene Med; 2000; 2(1):41-51. PubMed ID: 10765504
[TBL] [Abstract][Full Text] [Related]
3. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
Belalcazar LM; Merched A; Carr B; Oka K; Chen KH; Pastore L; Beaudet A; Chan L
Circulation; 2003 Jun; 107(21):2726-32. PubMed ID: 12742997
[TBL] [Abstract][Full Text] [Related]
4. Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene.
Kozarsky KF; Jooss K; Donahee M; Strauss JF; Wilson JM
Nat Genet; 1996 May; 13(1):54-62. PubMed ID: 8673104
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic approach to familial hypercholesterolemia by HVJ-liposomes in LDL receptor knockout mouse.
Tomita N; Morishita R; Koike H; Hashizume M; Notake M; Fujitani B; Kaneda Y; Horiuchi M; Ogihara T
Int J Mol Med; 2002 Aug; 10(2):137-43. PubMed ID: 12119548
[TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia.
Nomura S; Merched A; Nour E; Dieker C; Oka K; Chan L
Gene Ther; 2004 Oct; 11(20):1540-8. PubMed ID: 15269711
[TBL] [Abstract][Full Text] [Related]
7. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
[TBL] [Abstract][Full Text] [Related]
8. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
[TBL] [Abstract][Full Text] [Related]
9. Intravenous gene therapy for familial hypercholesterolemia using ligand-facilitated transfer of a liposome:LDL receptor gene complex.
Shichiri M; Tanaka A; Hirata Y
Gene Ther; 2003 May; 10(9):827-31. PubMed ID: 12704424
[TBL] [Abstract][Full Text] [Related]
10. Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice.
Parks BW; Lusis AJ; Kabarowski JH
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2703-9. PubMed ID: 16990555
[TBL] [Abstract][Full Text] [Related]
11. Enhanced plasma cholesterol lowering effect of retrovirus-mediated LDL receptor gene transfer to WHHL rabbit liver after improved surgical technique and stimulation of hepatocyte proliferation by combined partial liver resection and thymidine kinase--ganciclovir treatment.
Pakkanen TM; Laitinen M; Hippeläinen M; Kallionpää H; Lehtolainen P; Leppänen P; Luoma JS; Tarvainen R; Alhava E; Ylä-Herttuala S
Gene Ther; 1999 Jan; 6(1):34-41. PubMed ID: 10341873
[TBL] [Abstract][Full Text] [Related]
12. [Towards gene therapy in familial hypercholesterolemia].
Pagès JC; Andreoletti M; Loux N; Vons C; Mahieu D; Bargy F; Chapman J; Briand P; Franco D; Weber A
C R Seances Soc Biol Fil; 1996; 190(1):53-65. PubMed ID: 8881269
[TBL] [Abstract][Full Text] [Related]
13. Disruption of autosomal recessive hypercholesterolemia gene shows different phenotype in vitro and in vivo.
Harada-Shiba M; Takagi A; Marutsuka K; Moriguchi S; Yagyu H; Ishibashi S; Asada Y; Yokoyama S
Circ Res; 2004 Oct; 95(9):945-52. PubMed ID: 15472122
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus modifies cholesterol homeostasis in hepatic cells: a potential molecular mechanism for sirolimus-associated dyslipidemia.
Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
Transplantation; 2007 Oct; 84(8):1029-36. PubMed ID: 17989609
[TBL] [Abstract][Full Text] [Related]
15. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting.
Civeira F; Jarauta E; Cenarro A; García-Otín AL; Tejedor D; Zambón D; Mallen M; Ros E; Pocoví M
J Am Coll Cardiol; 2008 Nov; 52(19):1546-53. PubMed ID: 19007590
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy with novel adeno-associated virus vectors substantially diminishes atherosclerosis in a murine model of familial hypercholesterolemia.
Lebherz C; Gao G; Louboutin JP; Millar J; Rader D; Wilson JM
J Gene Med; 2004 Jun; 6(6):663-72. PubMed ID: 15170737
[TBL] [Abstract][Full Text] [Related]
17. Nonsense-mediated decay of human LDL receptor mRNA.
Holla ØL; Kulseth MA; Berge KE; Leren TP; Ranheim T
Scand J Clin Lab Invest; 2009; 69(3):409-17. PubMed ID: 19148831
[TBL] [Abstract][Full Text] [Related]
18. Regulation of hepatic cholesterol metabolism in CETP/LDLr mice by cholesterol feeding and by drugs (cholestyramine and lovastatin) that lower plasma cholesterol.
Harada LM; Carrilho AJ; Oliveira HC; Nakandakare ER; Quintão EC
Clin Exp Pharmacol Physiol; 2006 Dec; 33(12):1209-15. PubMed ID: 17184503
[TBL] [Abstract][Full Text] [Related]
19. Prospects for gene therapy of familial hypercholesterolemia.
Wilson JM; Chowdhury JR
Mol Biol Med; 1990 Jun; 7(3):223-32. PubMed ID: 2215209
[TBL] [Abstract][Full Text] [Related]
20. [Mutation screening and functional analysis of low density lipoprotein receptor in a familial hypercholesterolemia family].
Cheng XH; Zheng F; Zhou X; Xiong CL; Ding J; Chen YM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Feb; 25(1):55-8. PubMed ID: 18247305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
